ACS Diagnostics (ACS)
ACS Diagnostics (ACS) has established itself as a leading company in the field of ambulatory cardiac monitoring in the United States for over 35 years. Widely recognized in the field of Cardiology, ACS is particularly renowned for their Holter monitors and Holter analysis software. Several years ago, ACS ventured into the mobile cardiac telemetry (MCT) space after receiving approval from Medicare as an Independent Diagnostic Testing Facility (IDTF).
ACS has demonstrated its success as a Holter monitoring company by providing reliable devices at competitive prices. They claim to hold a significant share of the US market in the Holter Monitoring segment. Given their strong presence in Holter and event monitoring, it was only a matter of time before ACS introduced their proprietary mobile cardiac telemetry (MCT) monitor.
MCT Monitor Technology
ACS is excited to announce the recent launch of their latest multi-function monitor, the CORE¹² (Cardiac Outpatient Real-time ECG). ACS describes the CORE¹² as a “disruptive” device within the industry, as it is the first FDA-cleared device in the US that combines real-time 12-lead EKG, Holter monitoring, cardiac event monitoring, mobile cardiac telemetry monitoring, and 12-lead ECG for stress test monitoring all in one device.
For more information, please visit the ACS CORE Mobile Cardiac Telemetry (MCT) Monitor page.
Competitive Advantage
In addition to their product reliability, ACS stands out in the Mobile Cardiac Telemetry industry for providing cardiologists with greater flexibility in reimbursement structures for long-term monitoring services. According to ACS, most companies overlook the interests of physicians when it comes to structuring partnerships that generate more revenue for the referring physician. While ACS offers the traditional service model, they often prioritize solutions that provide greater revenue to the physician or medical facility. This approach represents a refreshing departure from the traditional service model where the service company retains all the revenue.
ACS is now an established player in the Mobile Cardiac Telemetry market, offering alternative solutions for physicians and medical facilities across the United States. The new CORE¹² monitor from ACS offers exceptional flexibility in ECG monitoring applications, improved economic returns, and cost savings for medical facilities by eliminating the need to invest in multiple ECG equipment.
Accreditation
ACS holds the status of an Independent Diagnostic Testing Facility (IDTF) from Medicare.
BBB Accreditation
ACS is recognized as a “Better Business Bureau Accredited Business.”
Legal & Safety Notice
Currently, there are no legal or public safety notices pertaining to ACS or their line of cardiac monitoring products.
Download Mobile Cardiac Telemetry Company Comparison